KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Change in Acquisitions & Divestments (2017 - 2025)

Teva Pharmaceutical Industries' Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $42.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $42.0 million, compared with a TTM value of $82.0 million through Dec 2025, up 105.0%, and an annual FY2025 reading of $42.0 million, up 5.0% over the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $42.0 million at Teva Pharmaceutical Industries, up from $40.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $107.0 million in Q2 2021, with the low at $1.0 million in Q3 2022.
  • Average Change in Acquisitions & Divestments over 4 years is $36.9 million, with a median of $40.0 million recorded in 2024.
  • Year-over-year, Change in Acquisitions & Divestments soared 3466.67% in 2021 and then tumbled 97.2% in 2022.
  • Tracing TEVA's Change in Acquisitions & Divestments over 4 years: stood at $19.0 million in 2021, then plummeted by 94.74% to $1.0 million in 2022, then surged by 3900.0% to $40.0 million in 2024, then rose by 5.0% to $42.0 million in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Change in Acquisitions & Divestments are $42.0 million (Q4 2025), $40.0 million (Q3 2024), and $1.0 million (Q3 2022).